C-MER MEDICAL (03309) announced on September 7 that it invested HK$70,000 to repurchase 80,000 shares.
Hema Medical (03309) announced that on September 7, 2026, it spent HKD 70,000 to repurchase 80,000 shares.
C-MER MEDICAL (03309) announced that it will repurchase 80,000 shares at a cost of HKD 70,000 on September 7, 2026.
Related Articles
Jiangsu Hengrui Pharmaceuticals (01276): HRS-1597 tablets have obtained the Drug Clinical Trial Approval Notice.
Semiconductor Manufacturing International Corporation (00981) issued 1,000 shares according to the equity plan.
YOUZAN (06051) spent HKD 1.0693 million to repurchase 900,000 shares on September 7.
Jiangsu Hengrui Pharmaceuticals (01276): HRS-1597 tablets have obtained the Drug Clinical Trial Approval Notice.
Semiconductor Manufacturing International Corporation (00981) issued 1,000 shares according to the equity plan.
YOUZAN (06051) spent HKD 1.0693 million to repurchase 900,000 shares on September 7.
RECOMMEND
